Historical record - last NADAC publication: 11/23/2022
Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1012 per EA under NDC 69238115405. Its NADAC has been published 284 times since Jul 12, 2017.
The High Outlier badge above means this manufacturer's average price in the Ezetimibe market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238115405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
11/23/2022
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA208803On Market Since
6/12/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 284 times since Jul 12, 2017, and over the history we have for it it has declined 98.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1012 per EA |
|---|---|
| All-time high | $6.9413 (Aug 16, 2017) |
| All-time low | $0.0980 (Jun 22, 2022) |
| Median price | $0.1826 |
| Average price | $0.3906 |
| Largest weekly change | -88.2% (Sep 20, 2017) |
| Weeks tracked | 284 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1012 per EA (NDC 69238115405), effective Dec 14, 2022.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 98.5%. It has been tracked across 284 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Jul 12, 2017, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0980 (Jun 22, 2022) to a high of $6.9413 (Aug 16, 2017), with a median of $0.1826 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0691 per EA — about 32% below EZETIMIBE 10 MG TABLET.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 69238115405) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification